Verified active February 2, 2026
Key Highlights
- Digitizing biomarker analysis for precision health advancements.
- Simoa technology offers ultra-sensitive detection capabilities.
- Founded in 2007, based in Billerica, Massachusetts.
- Public company with 547 employees in biotechnology research.
- Enables earlier disease detection and precise treatment methods.
About Quanterix
Quanterix is a leader in digitizing biomarker analysis, aiming to revolutionize precision health. Their proprietary Simoa technology offers ultra-sensitive detection, empowering researchers to deeply investigate the role of biomarkers across the health-to-disease spectrum. This innovation facilitates earlier disease detection, improved prognoses, and tailored treatments.
Serving researchers in oncology, neurology, cardiology, inflammation, and infectious diseases, Quanterix provides critical tools for advancing scientific understanding. Their platform enables a more profound examination of disease mechanisms, ultimately contributing to enhanced quality of life and longevity for future generations.
Established in 2007 and based in Billerica, Massachusetts, Quanterix operates as a public company with 547 employees, driving progress in biotechnology research.
Subsidiaries & Divisions
Uman Diagnostics
Technology Stack
- Simoa
- NF-Light
Why Contact Quanterix?
Quanterix provides ultra-sensitive biomarker analysis technology to enable earlier disease detection, better prognosis, and precise treatment methods, advancing the science of precision health.
Who Should Contact Quanterix for Business?
Researchers and healthcare professionals in oncology, neurology, cardiology, inflammation, and infectious disease research seeking advanced biomarker analysis tools.
Categories
- Biomarker Analysis
- Precision Health
- Simoa Technology
- Disease Detection
- Therapeutic Research
- Oncology
- Neurology
- Cardiology
- Inflammation
- Infectious Disease
More Biotechnology Companies
Frequently Asked Questions
- What does Quanterix do?
- Quanterix is a life sciences company that develops ultra-sensitive biomarker detection platforms, including its proprietary Simoa digital technology, for studying the biology of health and disease through the examination of proteins and nucleic acids.
- How many employees does Quanterix have?
- Quanterix has approximately 547 employees.
- Where is Quanterix headquartered?
- Billerica, Massachusetts, United States of America
- What industry is Quanterix in?
- Quanterix operates in Biotechnology, Healthcare Research, Precision Medicine.
- When was Quanterix founded?
- Quanterix was founded in 2007.
- What is the email format at Quanterix?
- Quanterix uses the email format flast@quanterix.com.
- Is Quanterix still active?
- Yes, Quanterix was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to Quanterix?
- Research Quanterix's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to Quanterix?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Discover Similar Companies
Find Decision Makers
Outreach Monitoring
Last verified: February 2, 2026
Backed by startup programs from
Connect with Quanterix